Russia Approves 2nd Coronavirus Vaccine - Putin
Speaking during a televised news conference, Putin said the new vaccine developed by Siberian biotech company Novosibirsk's Vektor [State Virology and Biotechnology Center], a former Soviet-era bioweapons lab.
Russia has an ongoing alliance in India for its first Covid-19 vaccine, Suptnik V. About a month ago, the Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories said they would collaborate to undertake clinical trials and distribution of the vaccine in India.
"Today, two Russian vaccines are in the clinical trial, while another one is registered".
Pharmaceutical giant Johnson & Johnson on Monday night announced that it had paused its late-stage COVID-19 vaccine trial after an "unexplained illness" was reported in a participant.
The trial is expected to involve 30,000 volunteers, of whom the first 5,000 will be residents of Siberia, according to the Interfax news agency.
Putin said that Deputy Prime Minister Tatyana Golikova and the head of Russia's consumer safety watchdog Anna Popova have both received the EpiVacCorona vaccine as part of clinical trials.
The AstraZeneca-Oxford Vaccine is now in the third phase of clinical trials.
Several companies are also using this approach to develop a vaccine, including USA companies Moderna and Pfizer whose candidates have reached late-stage trials.
Noting that clinical trials of a number of vaccine candidates were underway globally, Ms. Kamineni said Apollo Hospitals would follow government directions on which of the approved vaccines must be administered. The BBIBP-CorV vaccine used in this study is based on a sample of the virus that was isolated from a patient in China.
Three of them are in the U.S., while Bharat Biotech and Zydus Cadila have developed vaccine candidates in India. With a population of about 1.3 billion people, India will have to vaccinate around 900 million people to reach herd immunity.
"Most people agree that it's starting with healthcare workers and frontline workers, but even then you need to define which of them are at highest risk and then the elderly and so on", Swaminathan said at a press briefing yesterday.